Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder
Terminated
Allergan
Phase 3
2007-06-01
This study will assess the safety and efficacy of botulinum toxin Type A for the treatment of
urinary incontinence overactive bladder in patients with a spinal cord injury or multiple
sclerosis.
NT 201 (Xeomin®/Bocouture®) in Comparison With Clostridium Botulinum Toxin Type A in the Treatment of Glabellar Frown Lines
Completed
Merz Pharmaceuticals GmbH
Phase 3
2008-11-01
NT 201, also known as IncobotulinumtoxinA (Xeomin®/Bocouture®), is a Botulinum toxin type A
preparation free of complexing proteins (150 kiloDalton). Injected into the muscle, NT201
causes a reversible local relaxation of the injected muscle. Botulinum toxin type A is used
for aesthetic treatment of mimic wrinkles and in the therapy of neurologic diseases. This
study will investigate the safety and efficacy (non-inferiority) of NT 201 in comparison with
OnabotulinumtoxinA (Vistabel®) in the treatment of glabellar frown lines.
Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence
Completed
Allergan
Phase 3
2009-09-01
The purpose of this study is to assess the safety and effectiveness of botulinum toxin type A
(onabotulinumtoxinA) in treating patients with idiopathic overactive bladder with urinary
incontinence.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
